Vertex Pharmaceuticals (MA)'s $300,000 A Year Drug Is Denied, And Medicaid Patients Sue
18 Jul 2014
LITTLE ROCK, Ark.—Vertex Pharmaceuticals Inc.'s $300,000-a-year cystic-fibrosis drug has sparked a legal battle here, where the state's Medicaid program is restricting access to the expensive therapy.
In a lawsuit filed in Arkansas federal court last month, three people suffering from the fatal lung disease allege Medicaid officials have for two years denied them access to Kalydeco because of its cost. The plaintiffs allege state...
Help employers find you! Check out all the jobs and post your resume.
Organizations
Indications
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.